We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
Cap. Flow
-$324M
Cap. Flow %
-7.96%
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$31.9M
2
MCK icon
McKesson
MCK
+$27.5M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
SBUX icon
Starbucks
SBUX
+$27M
5
NVDA icon
NVIDIA
NVDA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 28.72%
2 Financials 13.85%
3 Technology 10.05%
4 Consumer Discretionary 8.55%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBIO
401
Crescent Biopharma
CBIO
$602M
$1.23M 0.03%
2,200
-150
-6% -$108K
FDX icon
402
FedEx
FDX
$74.5B
$1.22M 0.03%
8,485
-63,374
-88% -$10.1M
RLYP
403
DELISTED
RELYPSA INC COM
RLYP
$1.18M 0.03%
63,800
-1,200
-2% -$33K
MON
404
DELISTED
Monsanto Co
MON
$1.18M 0.03%
13,821
+5,500
+66% +$543K
VFC icon
405
VF Corp
VFC
$6.68B
$1.17M 0.03%
18,270
-69,754
-79% -$4.78M
D icon
406
Dominion Energy
D
$62.5B
$1.17M 0.03%
16,631
-5,747
-26% -$404K
BDSI
407
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.16M 0.03%
208,600
+28,600
+16% +$211K
FAST icon
408
Fastenal
FAST
$54B
$1.16M 0.03%
126,164
+71,552
+131% +$709K
DD
409
DELISTED
Du Pont De Nemours E I
DD
$1.15M 0.03%
23,852
+3,011
+14% +$161K
DNB
410
DELISTED
Dun & Bradstreet
DNB
$1.14M 0.03%
10,890
+2,179
+25% +$249K
KDNY
411
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.14M 0.03%
11,730
-405
-3% -$48.2K
HAL icon
412
Halliburton
HAL
$27.9B
$1.11M 0.03%
31,471
-104,940
-77% -$4.13M
PCP
413
DELISTED
PRECISION CASTPARTS CORP
PCP
$1.11M 0.03%
4,819
+51
+1% +$10.9K
SPY icon
414
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$1.09M 0.03%
5,689
-1,270
-18% -$258K
CI icon
415
Cigna
CI
$76.6B
$1.09M 0.03%
8,042
-61,586
-88% -$8.94M
BBD icon
416
Banco Bradesco
BBD
$38.1B
$1.07M 0.03%
426,450
-295,497
-41% -$995K
INFY icon
417
Infosys
INFY
$45B
$1.07M 0.03%
112,000
BBWI icon
418
Bath & Body Works
BBWI
$4.01B
$1.07M 0.03%
14,639
-2,761
-16% -$191K
CALA
419
DELISTED
Calithera Biosciences, Inc
CALA
$1.06M 0.03%
9,750
-1,750
-15% -$227K
PVH icon
420
PVH
PVH
$3.71B
$1.05M 0.03%
10,275
-38,765
-79% -$4.41M
RDY icon
421
Dr. Reddy's Laboratories
RDY
$9.82B
$1.02M 0.03%
80,000
-20,000
-20% -$248K
ABUS icon
422
Arbutus Biopharma
ABUS
$865M
$1.02M 0.03%
167,600
-14,400
-8% -$128K
DTE icon
423
DTE Energy
DTE
$31.1B
$1.02M 0.03%
14,863
ROP icon
424
Roper Technologies
ROP
$36.3B
$1.01M 0.02%
6,423
+911
+17% +$151K
ENB icon
425
Enbridge
ENB
$124B
$1M 0.02%
27,080
+4,093
+18% +$171K

Similar funds

Candriam SCA's Q3 2015 Portfolio in Review

As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.

  • Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
  • Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
  • Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
  • Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
  • Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
  • Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.